Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

UPDATE: Inovio Pharmaceuticals Q3 Adj. EPS $(0.44) Misses $(0.42) Estimate

Author: Benzinga Newsdesk | November 10, 2025 06:44pm
Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.42) by 4.02 percent. This is a 50.56 percent increase over losses of $(0.89) per share from the same period last year.

Posted In: INO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist